Australia markets close in 4 hours 36 minutes
  • ALL ORDS

    7,644.80
    +67.60 (+0.89%)
     
  • ASX 200

    7,387.80
    +75.50 (+1.03%)
     
  • AUD/USD

    0.7706
    -0.0008 (-0.10%)
     
  • OIL

    71.45
    +0.57 (+0.80%)
     
  • GOLD

    1,862.90
    -3.00 (-0.16%)
     
  • BTC-AUD

    52,284.38
    +1,340.68 (+2.63%)
     
  • CMC Crypto 200

    1,008.09
    +39.25 (+4.05%)
     
  • AUD/EUR

    0.6357
    -0.0004 (-0.07%)
     
  • AUD/NZD

    1.0793
    -0.0002 (-0.02%)
     
  • NZX 50

    12,661.51
    +99.34 (+0.79%)
     
  • NASDAQ

    14,128.20
    +129.90 (+0.93%)
     
  • FTSE

    7,146.68
    +12.62 (+0.18%)
     
  • Dow Jones

    34,393.75
    -85.85 (-0.25%)
     
  • DAX

    15,673.64
    -19.63 (-0.13%)
     
  • Hang Seng

    28,946.44
    +104.31 (+0.36%)
     
  • NIKKEI 225

    29,446.24
    +284.44 (+0.98%)
     

Global Scaffold Technology Market to Reach $1.7 Billion by 2027

·15-min read

Abstract: - Global Scaffold Technology Market to Reach $1. 7 Billion by 2027. - Amid the COVID-19 crisis, the global market for Scaffold Technology estimated at US$1 Billion in the year 2020, is projected to reach a revised size of US$1.

New York, June 11, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Scaffold Technology Industry" - https://www.reportlinker.com/p06032835/?utm_source=GNW
7 Billion by 2027, growing at a CAGR of 7.7% over the analysis period 2020-2027. Hydrogels, one of the segments analyzed in the report, is projected to record a 8% CAGR and reach US$772.5 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Polymeric Scaffolds segment is readjusted to a revised 6.8% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $303.4 Million, While China is Forecast to Grow at 7.2% CAGR
- The Scaffold Technology market in the U.S. is estimated at US$303.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$300.6 Million by the year 2027 trailing a CAGR of 7.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.2% and 6.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 6.3% CAGR.
- Micropatterned Surface Microplates Segment to Record 7.3% CAGR
- In the global Micropatterned Surface Microplates segment, USA, Canada, Japan, China and Europe will drive the 7.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$117.3 Million in the year 2020 will reach a projected size of US$192.8 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$198.9 Million by the year 2027.

- Select Competitors (Total 34 Featured) -

  • 3D Biotek LLC

  • Avacta Life Sciences Limited

  • Becton

  • Corning Inc.

  • Dickinson and Company

  • Marticel GmbH

  • Merck and Company

  • Molecular Matrix Inc.

  • Nanofiber Solutions

  • NuVasive, Inc.

  • Pelo Biotech GmbH

  • ReproCELL Europe Ltd.

  • Tecan Trading AG

  • Thermo Fisher Scientific Inc.




Read the full report: https://www.reportlinker.com/p06032835/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Scaffold
Technology by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 2: World 7-Year Perspective for Scaffold Technology by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets for Years 2020 & 2027

Table 3: World Current & Future Analysis for Hydrogels by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 4: World 7-Year Perspective for Hydrogels by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2020 & 2027

Table 5: World Current & Future Analysis for Polymeric
Scaffolds by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 6: World 7-Year Perspective for Polymeric Scaffolds by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2020 & 2027

Table 7: World Current & Future Analysis for Micropatterned
Surface Microplates by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 8: World 7-Year Perspective for Micropatterned Surface
Microplates by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2020 & 2027

Table 9: World Current & Future Analysis for Nanofiber Based
Scaffolds by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 10: World 7-Year Perspective for Nanofiber Based
Scaffolds by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2020 & 2027

Table 11: World Current & Future Analysis for Biotech & Pharma
Companies by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 12: World 7-Year Perspective for Biotech & Pharma
Companies by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2020 & 2027

Table 13: World Current & Future Analysis for Research
Laboratories & Institutes by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 14: World 7-Year Perspective for Research Laboratories &
Institutes by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2020 & 2027

Table 15: World Current & Future Analysis for Hospitals &
Diagnostic Centers by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 16: World 7-Year Perspective for Hospitals & Diagnostic
Centers by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2020 & 2027

Table 17: World Current & Future Analysis for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 18: World 7-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 19: USA Current & Future Analysis for Scaffold Technology
by Type - Hydrogels, Polymeric Scaffolds, Micropatterned
Surface Microplates and Nanofiber Based Scaffolds - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 20: USA 7-Year Perspective for Scaffold Technology by
Type - Percentage Breakdown of Value Sales for Hydrogels,
Polymeric Scaffolds, Micropatterned Surface Microplates and
Nanofiber Based Scaffolds for the Years 2020 & 2027

Table 21: USA Current & Future Analysis for Scaffold Technology
by End-Use - Biotech & Pharma Companies, Research Laboratories &
Institutes, Hospitals & Diagnostic Centers and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 22: USA 7-Year Perspective for Scaffold Technology by
End-Use - Percentage Breakdown of Value Sales for Biotech &
Pharma Companies, Research Laboratories & Institutes, Hospitals &
Diagnostic Centers and Other End-Uses for the Years 2020 &
2027

CANADA
Table 23: Canada Current & Future Analysis for Scaffold
Technology by Type - Hydrogels, Polymeric Scaffolds,
Micropatterned Surface Microplates and Nanofiber Based
Scaffolds - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 24: Canada 7-Year Perspective for Scaffold Technology by
Type - Percentage Breakdown of Value Sales for Hydrogels,
Polymeric Scaffolds, Micropatterned Surface Microplates and
Nanofiber Based Scaffolds for the Years 2020 & 2027

Table 25: Canada Current & Future Analysis for Scaffold
Technology by End-Use - Biotech & Pharma Companies, Research
Laboratories & Institutes, Hospitals & Diagnostic Centers and
Other End-Uses - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 26: Canada 7-Year Perspective for Scaffold Technology by
End-Use - Percentage Breakdown of Value Sales for Biotech &
Pharma Companies, Research Laboratories & Institutes, Hospitals &
Diagnostic Centers and Other End-Uses for the Years 2020 &
2027

JAPAN
Table 27: Japan Current & Future Analysis for Scaffold
Technology by Type - Hydrogels, Polymeric Scaffolds,
Micropatterned Surface Microplates and Nanofiber Based
Scaffolds - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 28: Japan 7-Year Perspective for Scaffold Technology by
Type - Percentage Breakdown of Value Sales for Hydrogels,
Polymeric Scaffolds, Micropatterned Surface Microplates and
Nanofiber Based Scaffolds for the Years 2020 & 2027

Table 29: Japan Current & Future Analysis for Scaffold
Technology by End-Use - Biotech & Pharma Companies, Research
Laboratories & Institutes, Hospitals & Diagnostic Centers and
Other End-Uses - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 30: Japan 7-Year Perspective for Scaffold Technology by
End-Use - Percentage Breakdown of Value Sales for Biotech &
Pharma Companies, Research Laboratories & Institutes, Hospitals &
Diagnostic Centers and Other End-Uses for the Years 2020 &
2027

CHINA
Table 31: China Current & Future Analysis for Scaffold
Technology by Type - Hydrogels, Polymeric Scaffolds,
Micropatterned Surface Microplates and Nanofiber Based
Scaffolds - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 32: China 7-Year Perspective for Scaffold Technology by
Type - Percentage Breakdown of Value Sales for Hydrogels,
Polymeric Scaffolds, Micropatterned Surface Microplates and
Nanofiber Based Scaffolds for the Years 2020 & 2027

Table 33: China Current & Future Analysis for Scaffold
Technology by End-Use - Biotech & Pharma Companies, Research
Laboratories & Institutes, Hospitals & Diagnostic Centers and
Other End-Uses - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 34: China 7-Year Perspective for Scaffold Technology by
End-Use - Percentage Breakdown of Value Sales for Biotech &
Pharma Companies, Research Laboratories & Institutes, Hospitals &
Diagnostic Centers and Other End-Uses for the Years 2020 &
2027

EUROPE
Table 35: Europe Current & Future Analysis for Scaffold
Technology by Geographic Region - France, Germany, Italy, UK
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

Table 36: Europe 7-Year Perspective for Scaffold Technology by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK and Rest of Europe Markets for Years
2020 & 2027

Table 37: Europe Current & Future Analysis for Scaffold
Technology by Type - Hydrogels, Polymeric Scaffolds,
Micropatterned Surface Microplates and Nanofiber Based
Scaffolds - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 38: Europe 7-Year Perspective for Scaffold Technology by
Type - Percentage Breakdown of Value Sales for Hydrogels,
Polymeric Scaffolds, Micropatterned Surface Microplates and
Nanofiber Based Scaffolds for the Years 2020 & 2027

Table 39: Europe Current & Future Analysis for Scaffold
Technology by End-Use - Biotech & Pharma Companies, Research
Laboratories & Institutes, Hospitals & Diagnostic Centers and
Other End-Uses - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 40: Europe 7-Year Perspective for Scaffold Technology by
End-Use - Percentage Breakdown of Value Sales for Biotech &
Pharma Companies, Research Laboratories & Institutes, Hospitals &
Diagnostic Centers and Other End-Uses for the Years 2020 &
2027

FRANCE
Table 41: France Current & Future Analysis for Scaffold
Technology by Type - Hydrogels, Polymeric Scaffolds,
Micropatterned Surface Microplates and Nanofiber Based
Scaffolds - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 42: France 7-Year Perspective for Scaffold Technology by
Type - Percentage Breakdown of Value Sales for Hydrogels,
Polymeric Scaffolds, Micropatterned Surface Microplates and
Nanofiber Based Scaffolds for the Years 2020 & 2027

Table 43: France Current & Future Analysis for Scaffold
Technology by End-Use - Biotech & Pharma Companies, Research
Laboratories & Institutes, Hospitals & Diagnostic Centers and
Other End-Uses - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 44: France 7-Year Perspective for Scaffold Technology by
End-Use - Percentage Breakdown of Value Sales for Biotech &
Pharma Companies, Research Laboratories & Institutes, Hospitals &
Diagnostic Centers and Other End-Uses for the Years 2020 &
2027

GERMANY
Table 45: Germany Current & Future Analysis for Scaffold
Technology by Type - Hydrogels, Polymeric Scaffolds,
Micropatterned Surface Microplates and Nanofiber Based
Scaffolds - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 46: Germany 7-Year Perspective for Scaffold Technology by
Type - Percentage Breakdown of Value Sales for Hydrogels,
Polymeric Scaffolds, Micropatterned Surface Microplates and
Nanofiber Based Scaffolds for the Years 2020 & 2027

Table 47: Germany Current & Future Analysis for Scaffold
Technology by End-Use - Biotech & Pharma Companies, Research
Laboratories & Institutes, Hospitals & Diagnostic Centers and
Other End-Uses - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 48: Germany 7-Year Perspective for Scaffold Technology by
End-Use - Percentage Breakdown of Value Sales for Biotech &
Pharma Companies, Research Laboratories & Institutes, Hospitals &
Diagnostic Centers and Other End-Uses for the Years 2020 &
2027

ITALY
Table 49: Italy Current & Future Analysis for Scaffold
Technology by Type - Hydrogels, Polymeric Scaffolds,
Micropatterned Surface Microplates and Nanofiber Based
Scaffolds - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 50: Italy 7-Year Perspective for Scaffold Technology by
Type - Percentage Breakdown of Value Sales for Hydrogels,
Polymeric Scaffolds, Micropatterned Surface Microplates and
Nanofiber Based Scaffolds for the Years 2020 & 2027

Table 51: Italy Current & Future Analysis for Scaffold
Technology by End-Use - Biotech & Pharma Companies, Research
Laboratories & Institutes, Hospitals & Diagnostic Centers and
Other End-Uses - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 52: Italy 7-Year Perspective for Scaffold Technology by
End-Use - Percentage Breakdown of Value Sales for Biotech &
Pharma Companies, Research Laboratories & Institutes, Hospitals &
Diagnostic Centers and Other End-Uses for the Years 2020 &
2027

UNITED KINGDOM
Table 53: UK Current & Future Analysis for Scaffold Technology
by Type - Hydrogels, Polymeric Scaffolds, Micropatterned
Surface Microplates and Nanofiber Based Scaffolds - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 54: UK 7-Year Perspective for Scaffold Technology by Type -
Percentage Breakdown of Value Sales for Hydrogels, Polymeric
Scaffolds, Micropatterned Surface Microplates and Nanofiber
Based Scaffolds for the Years 2020 & 2027

Table 55: UK Current & Future Analysis for Scaffold Technology
by End-Use - Biotech & Pharma Companies, Research Laboratories &
Institutes, Hospitals & Diagnostic Centers and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 56: UK 7-Year Perspective for Scaffold Technology by
End-Use - Percentage Breakdown of Value Sales for Biotech &
Pharma Companies, Research Laboratories & Institutes, Hospitals &
Diagnostic Centers and Other End-Uses for the Years 2020 &
2027

REST OF EUROPE
Table 57: Rest of Europe Current & Future Analysis for Scaffold
Technology by Type - Hydrogels, Polymeric Scaffolds,
Micropatterned Surface Microplates and Nanofiber Based
Scaffolds - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 58: Rest of Europe 7-Year Perspective for Scaffold
Technology by Type - Percentage Breakdown of Value Sales for
Hydrogels, Polymeric Scaffolds, Micropatterned Surface
Microplates and Nanofiber Based Scaffolds for the Years 2020 &
2027

Table 59: Rest of Europe Current & Future Analysis for Scaffold
Technology by End-Use - Biotech & Pharma Companies, Research
Laboratories & Institutes, Hospitals & Diagnostic Centers and
Other End-Uses - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 60: Rest of Europe 7-Year Perspective for Scaffold
Technology by End-Use - Percentage Breakdown of Value Sales for
Biotech & Pharma Companies, Research Laboratories & Institutes,
Hospitals & Diagnostic Centers and Other End-Uses for the Years
2020 & 2027

ASIA-PACIFIC
Table 61: Asia-Pacific Current & Future Analysis for Scaffold
Technology by Type - Hydrogels, Polymeric Scaffolds,
Micropatterned Surface Microplates and Nanofiber Based
Scaffolds - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 62: Asia-Pacific 7-Year Perspective for Scaffold
Technology by Type - Percentage Breakdown of Value Sales for
Hydrogels, Polymeric Scaffolds, Micropatterned Surface
Microplates and Nanofiber Based Scaffolds for the Years 2020 &
2027

Table 63: Asia-Pacific Current & Future Analysis for Scaffold
Technology by End-Use - Biotech & Pharma Companies, Research
Laboratories & Institutes, Hospitals & Diagnostic Centers and
Other End-Uses - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 64: Asia-Pacific 7-Year Perspective for Scaffold
Technology by End-Use - Percentage Breakdown of Value Sales for
Biotech & Pharma Companies, Research Laboratories & Institutes,
Hospitals & Diagnostic Centers and Other End-Uses for the Years
2020 & 2027

REST OF WORLD
Table 65: Rest of World Current & Future Analysis for Scaffold
Technology by Type - Hydrogels, Polymeric Scaffolds,
Micropatterned Surface Microplates and Nanofiber Based
Scaffolds - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 66: Rest of World 7-Year Perspective for Scaffold
Technology by Type - Percentage Breakdown of Value Sales for
Hydrogels, Polymeric Scaffolds, Micropatterned Surface
Microplates and Nanofiber Based Scaffolds for the Years 2020 &
2027

Table 67: Rest of World Current & Future Analysis for Scaffold
Technology by End-Use - Biotech & Pharma Companies, Research
Laboratories & Institutes, Hospitals & Diagnostic Centers and
Other End-Uses - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 68: Rest of World 7-Year Perspective for Scaffold
Technology by End-Use - Percentage Breakdown of Value Sales for
Biotech & Pharma Companies, Research Laboratories & Institutes,
Hospitals & Diagnostic Centers and Other End-Uses for the Years
2020 & 2027

IV. COMPETITION
Total Companies Profiled: 34
Read the full report: https://www.reportlinker.com/p06032835/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001